Drug profile · INN
clavulanate potassium
TIMENTIN
clavulanate potassium (TIMENTIN) is a bacterial beta-lactamase tem inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — clavulanate potassium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
clavulanate potassium (TIMENTIN) is a bacterial beta-lactamase tem inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial beta-lactamase TEM inhibitor
Primary target: Beta-lactamase TEM
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is clavulanate potassium?
clavulanate potassium (TIMENTIN) is a bacterial beta-lactamase tem inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for clavulanate potassium?
TIMENTIN is a marketed brand name for clavulanate potassium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of clavulanate potassium?
clavulanate potassium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.